A tunable, non-editing method to knockdown gene expression in Pseudomonas putida for metabolic engineering and functional genomics studies.
CRISPRi enables precise, scalable gene repression without the genetic scars or lethal effects of traditional knockouts, making it ideal for essential genes and tunable pathway control.
Catalytically dead dCas9 guided by custom sgRNAs to block transcription at promoter or coding regions.
In silico design of guide RNAs targeting your gene of interest, with off-target prediction and efficiency scoring.
Cloning of selected sgRNAs into a optimized CRISPRi vector with dCas9-repressor and inducible promoter for robust expression.
Tight regulation of dCas9 expression using well-characterized promoters (e.g., PrhaBAD, XylS/Pm) for conditional repression.
Co-expression of multiple sgRNAs from a single vector enables simultaneous repression of several targets in one strain.
Optional characterization of growth, product yield, or stress tolerance to link repression with functional outcomes.
Each project delivers engineered strains, validated repression data, and project documentation.
Each project is defined by a case-by-case scope. Typical parameters include:
| Parameter | Typical project scope |
|---|---|
| Host Strain | P. putida KT2440 (preferred); other P. putida strains evaluated per project. |
| Target Genes | Up to 5 genes per project; additional targets scoped separately. |
| sgRNAs per Target | Scoped per project after consultation |
| Vector System | DCas9-repressor with inducible promoter (e.g., PrhaBAD or XylS/Pm); antibiotic marker as agreed. |
| Repression assessment | QRT-PCR (default) or reporter assay; fold-change reported relative to control. |
| Optional Phenotyping | Growth curves, metabolite profiling, or stress assays — included when scoped. |
| Technical Support | Named scientific contact at project start; milestone review calls; email response within 1 business day |
A streamlined 5-step process from target design to validated strain delivery.
Identify target gene(s), design custom sgRNAs against promoter or coding regions, and synthesize oligonucleotides for cloning.
Clone each sgRNA into a CRISPRi vector carrying dCas9-repressor and an inducible promoter; sequence investigate the construct.
Transform P. putida with the verified plasmid via electroporation; plate on selective medium and confirm integration by colony PCR.
Induce dCas9 expression, harvest RNA, and perform qRT-PCR to measure knockdown efficiency relative to a control strain.
Assess growth phenotype, prepare glycerol stocks, and compile a data package with QC results and a final report.
Our service supports a range of research and engineering goals in Pseudomonas putida.
Knock down competing pathways to evaluate production of biochemicals, such as polyketides, aromatics, or terpenoids.
Inducible knockdown reveals essential genes under specific conditions without permanent loss.
Probe the roles of transcriptional regulators in tolerance to solvents, oxidative stress, or nutrient limitation.
Answers to typical project inquiries.
CRISPR knockout uses Cas9 nuclease to create double-strand breaks that permanently disrupt the gene, while CRISPRi employs a catalytically dead dCas9 fused to a repressor domain to reversibly block transcription without altering the genome. CRISPRi is ideal for essential genes or when tunable control is needed, and it avoids selective pressure for loss-of-function mutations.
Yes, our system supports multiplex CRISPRi by co-expressing several sgRNAs from a single vector or using arrayed constructs. We can design and test up to five target genes per project. Repression efficiency for each target is validated individually by qRT-PCR.
Each strain undergoes sequence confirmation of the CRISPRi construct via Sanger sequencing, colony PCR to verify plasmid maintenance, and qRT-PCR to quantify target gene knockdown (typically project-dependent performance that is verified during development repression, depending on target and sgRNA). Growth curves are also recorded to evaluate any fitness effects.
Our system is primarily optimized for P. putida KT2440. Adaptation to other P. putida strains (e.g., P. putida M2, P. alloputida) is possible on a case-by-case basis and may require promoter or marker adjustments. We recommend discussing your specific strain during the initial consultation.
Get a customized quote for your Pseudomonas putida CRISPRi Gene Repression project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.